Valerio Forte

Valerio Forte

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Current Medical Imaging
Verified
Journal Article
Open access
PDF file
ACArmando Ugo Cavallo
Armando Ugo Cavallo
Jacopo TroisiJacopo Troisi
Jacopo Troisi
MFMarco Forcina
Marco Forcina
Pier Valerio MariPier Valerio Mari
Pier Valerio Mari
VFValerio Forte
Valerio Forte
FGFrancesco Garaci
Francesco Garaci
Background: One of the most challenging aspects related to Covid-19 is to establish the presence of infection in early phase of the disease. Texture analysis might be an additional tool for the evaluation of Chest X-ray in patients with clinical suspicion of Covid-19 related pneumonia. Objective: To evaluate the diagnostic performance of texture analysis and machine learning models for the diagnosis of Covid-19 interstitial pneumonia in Chest X-ray images. Methods: Chest X-ray images were accessed from a publicly available repository (https://www.kaggle.com/tawsifurrahman/covid19-radiography-database). Lung areas were manually segmented using a polygonal regions of interest covering both lung areas, using MaZda, a freely available software for texture analysis. A total of 308 features per ROI was extracted. One hundred-ten Covid-19 Chest X-ray images were selected for the final analysis. Results: Six models, namely NB, GLM, DL, GBT, ANN and PLS-DA were selected and ensembled. According to Youden’s index, the Covid-19 Ensemble Machine Learning Score showing the highest Area Under the Curve (0.971±0.015) was 132.57. Assuming this cut-off the Ensemble model performance was estimated evaluating both true and false positive/negative, resulting in 91.8% accuracy with 93% sensitivity and 90% specificity. Moving the cut-off value to -100, although the accuracy resulted lower (90.6%), the Ensemble Machine Learning showed 100% sensitivity, with 80% specificity. Conclusion: Texture analysis of Chest X-ray images and machine learning algorithms may help in differentiating patients with Covid-19 pneumonia. Despite several limitations, this study can lay ground for future researches in this field and help developing more rapid and accurate screening tools for these patients.

21 June 2022 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
VIValerio Iacovelli
Valerio Iacovelli
MCM. Carilli
M. Carilli
Marco SandriMarco Sandri
Marco Sandri
VFValerio Forte
Valerio Forte
CCC. Cipriani
C. Cipriani
PBP. Bove
P. Bove

23 July 2024 in Cancers
Verified
Journal Article
Open access
PDF file
VIValerio Iacovelli
Valerio Iacovelli
MCMarco Carilli
Marco Carilli
Riccardo BertoloRiccardo Bertolo
Riccardo Bertolo
VFValerio Forte
Valerio Forte
MVMatteo Vittori
Matteo Vittori
PBPierluigi Bove
Pierluigi Bove
Introduction and objectives: To evaluate the oncological and functional outcomes of transperineal laser ablation (TPLA) as the focal therapy for localized prostate cancer (PCa) after a 12-month follow-up. Materials and methods: Patients with low- and intermediate-risk localized PCa were prospectively treated with focal TPLA between July 2021 and December 2022. The inclusion criteria were the following: clinical stage < T2b; PSA < 20 ng/mL; International Society of Urological Pathology (ISUP) grade ≤ 2; MRI-fusion biopsy-confirmed lesion classified as PI-RADS v2.1 ≥ 3. Intra-, peri-, and post-operative data were collected. Variables including age, PSA, prostate volume (PVol), Charlson’s Comorbidity Index (CCI), International Prostate Symptom Score (IPSS) with QoL score, International Index of Erectile Function (IIEF-5), International Consultation on Incontinence Questionnaire—Short Form (ICIQ-SF), and Male Sexual Health Questionnaire—Ejaculatory Dysfunction Short Form (MSHQ-EjD) were collected at baseline and at 3, 6 and 12 months after TPLA. Post-operative mpMRI was performed at 3 and 12 months. Finally, all patients underwent prostatic re-biopsy under fusion guidance at 12 months. The success of this technique was defined as no recurrence in the target treated lesion at the 12-month follow up. Results: Twenty-four patients underwent focal TPLA. Baseline features were age [median 67 years (IQR 12)], PSA [5.7 ng/mL (3.9)], PVol [49 mL (27)], CCI [0 (0)], IPSS [11 (9)], IPSS-QoL [2 (2)], IIEF-5 [21 (6)], ICIQ-SF [0 (7)], MSHQ-EjD ejaculation domain [14 (4)] and bother score [0 (2)]. Median operative time was 34 min (IQR 12). Median visual analogue scale (VAS) 6 h after TPLA was 0 (IQR 1). The post-operative course was regular for all patients, who were discharged on the second post-operative day and underwent catheter removal on the seventh post-operative day. No patient had incontinence at catheter removal. A significant reduction in PSA (p = 0.01) and an improvement in IPSS (p = 0.009), IPSS-QoL (p = 0.02) and ICIQ-SF scores (p = 0.04) compared to baseline were observed at the 3-month follow-up. Erectile and ejaculatory functions did not show any significant variation during the follow-up. No intra- and peri-operative complications were recorded. Three Clavien–Dindo post-operative complications were recorded (12%): grade 1 (two cases of urinary retention) and grade 2 (one case of urinary tract infection). At the 12-month follow-up, eight patients showed mpMRI images referable to suspicious recurrent disease (PIRADS v2.1 ≥ 3). After re-biopsy, 7/24 patients’ (29%) results were histologically confirmed as PCa, 3 of which were recurrences in the treated lesion (12.5%). The success rate was 87.5%. Conclusions: The focal TPLA oncological and functional results seemed to be encouraging. TPLA is a safe, painless, and effective technique with a good preservation of continence and sexual outcomes. Recurrence rate at 12 months was about 12.5%.

27 January 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
ACArmando Ugo Cavallo
Armando Ugo Cavallo
Jacopo TroisiJacopo Troisi
Jacopo Troisi
EMEmanuele Muscogiuri
Emanuele Muscogiuri
Pierpaolo CavalloPierpaolo Cavallo
Pierpaolo Cavallo
SRsanjay Rajagopalan
sanjay Rajagopalan
MSMassimiliano Sperandio
Massimiliano Sperandio
The aim of the study is to verify the feasibility of a radiomics based approach for the detection of LV remodeling in patients with arterial hypertension. Cardiac Computed Tomography (CCT) and clinical data of patients with and without history of arterial hypertension were collected. In one image per patient, on a 4-chamber view, left ventricle (LV) was segmented using a polygonal region of interest by two radiologists in consensus. A total of 377 radiomics features per region of interest were extracted. After dataset splitting (70:30 ratio), eleven classification models were tested for the discrimination of patients with and without arterial hypertension based on radiomics data. An Ensemble Machine Learning (EML) score was calculated from models with an accuracy >60%. Boruta algorithm was used to extract radiomic features discriminating between patients with and without history of hypertension. Pearson correlation coefficient was used to assess correlation between EML score and septum width in patients included in the test set. EML showed an accuracy, sensitivity and specificity of 0.7. Correlation between EML score and LV septum width was 0.53 (p-value < 0.0001). We considered LV septum width as a surrogate of myocardial remodeling in our population, and this is the reason why we can consider the EML score as a possible tool to evaluate myocardial remodeling. A CCT-based radiomic approach for the identification of LV remodeling is possible in patients with past medical history of arterial hypertension.

17 July 2020 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
VFValerio Forte
Valerio Forte
ACA. U. Cavallo
A. U. Cavallo
Riccardo BertoloRiccardo Bertolo
Riccardo Bertolo
VSV. de Soccio
V. de Soccio
MSM. Sperandio
M. Sperandio
MCM. Ciccariello
M. Ciccariello

1 October 2021 in Progrès en Urologie
Verified
Journal Article
Closed access
Riccardo BertoloRiccardo Bertolo
Riccardo Bertolo
MVMatteo Vittori
Matteo Vittori
CCChiara Cipriani
Chiara Cipriani
FMF. Maiorino
F. Maiorino
VFValerio Forte
Valerio Forte
PBPierluigi Bove
Pierluigi Bove